IJCS | Volume 32, Nº2, May/June 2019

267 1. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 Study. Circulation. 2014;129(14):1483-92. 2. Brasil.Ministério da Saúde Secretaria Executiva. Departamento de Informática do DATASUS. Informações de saúde. Morbidade e informações epidemiológicas. Brasília (DF);2010. [citado 2016 nov 16]. Disponível em: www2datasus.gov.br/DATASUS/indexphp?area=0203. 3. Mack M, Gopal A. Epidemiology, traditional and novel risk factors in coronary artery disease. Cardiol Clin. 2014;32(3):323-32. 4. O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J AmColl Cardiol. 2007;50(11):1009-14. 5. Hvidtfeldt UA, Tolstrup JS, Jakobsen MU, Heitmann BL, Grønbaek M, O'Reilly E, et al. Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation. 2010;121(14):1589-97. 6. Mukamal KJ, Chung H, Jenny NS, Kuller LH, Longstreth WT Jr, Mittleman MA, et al. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54(1):30-7. 7. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther. 2008;6(6):883-95. 8. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking- attributable mortality in 2000. Tob Control. 2004;13(4):388-95. 9. ThunMJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368(4):351-64. 10. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341-50. 11. Bacci MR, Fonseca FL, Nogueira LF, Bruniera FR, Ferreira FM, Barros DM, et al. Predominance of STEMI and severity of coronary artery disease in a cohort of patients hospitalized with acute coronary syndrome: a report from ABC Medical School. Rev Assoc Med Bras. 2015;61(3):240-3. 12. Bastos AS, Beccaria LM, Contrin LM, Cesarino CB. Time of arrival of patients with acute myocardial infarction to the emergency department. Rev Bras Cir Cardiovasc. 2012;27(3):411-8. 13. Soares JS, Souza NR, Nogueira Filho J, Cunha CC, Ribeiro GS, Peixoto RS, et al. Treatment of a cohort of patients with acute myocardial infarction and ST-segment elevation. Arq Bras Cardiol. 2009;92(6):430-6. 14. Caluza AC, Barbosa AH, Gonçalves I, Oliveira CA, Matos LN, Zeefried C, et al. ST-elevation myocardial infarction network: systematization in 205 cases reduced clinical events in the public health care system. Arq Bras Cardiol. 2012;99(5):1040-8. 15. Santos ES, Minuzzo L, Pereira MP, Castillo MT, Palácio MA, Ramos RF, et al. Acute coronary syndrome registry at a cardiology emergency center. Arq Bras Cardiol. 2006;87(5):597-602. 16. Femia R, Natali A, L’Abbate A, Ferrannini E. Coronary atherosclerosis and alcohol consumption: angiographic andmortality data. Arterioscler Thromb Vasc Biol. 2006;26(7):1607-12. 17. Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, et al. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevationmyocardial infarction. J Am Coll Cardiol. 2005;45(2):321-3. 18. Weisz G, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker’s paradox revisited. Am Heart J. 2005;150(2):358-64. 19. Angeja BG, Kermgard S, ChenMS, McKayM, Murphy SA, Antman EM, et al. The smoker’s paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis. 2002;13(3):133-9. 20. Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowsi Z, et al.Evaluationofparadoxicbeneficialeffectsofsmokinginpatientsreceiving thrombolytic therapy for acute myocardial infarction: mechanism of the “smoker’s paradox” from the GUSTO-I trial, with angiographic insights. Global utilization of streptokinase and tissue-plasminogen activator for occluded coronary arteries. J Am Coll Cardiol. 1995;26(5):1222-9. 21. Grines CL, Topol EJ, O’Neill WW, George BS, Kereiakes D, Phillips HR, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation. 1995;91(2):298-303. 22. Gomez MA, Karagounis LA, Allen A, Anderson JL. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction. Am J Cardiol. 1993;72(5):373-8. 23. Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Califf RM, Ross AM. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct- related artery and choice of thrombolytic regimen: the GUSTO-I experience. J Am Coll Cardiol. 1998;32(3):641-7. 24. Gurbel PA, Bliden KP, Logan DK, Kereiakes DJ, Lasseter KC, White A, et al. The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the paradox study. J Am Coll Cardiol. 2013;62(6):505-12. 25. Ferreiro JL, Bhatt DL, UenoM, Bauer D, Angiolillo DJ. Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (clopidogrel versus aspirin in patients at risk of ischemic events). J Am Coll Cardiol. 2014;63(8):769-77. 26. Gupta T, Kolte D, Khera S, Harikrishnan P, Mujib M, Aronow WS, et al. Smoker’s paradox in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Am Heart Assoc. 2016;5(4): e003370. 27. Skliros EA, Papadodima SA, Sotiropoulos A, Xipnitos C, Kollias A, Spiliopoulou CA. Relationship between alcohol consumption and control References Albuquerque et al. Association smoking and alcohol consumption AMI Int J Cardiovasc Sci. 2019;32(3)261-268 Original Article Sources of Funding There were no external funding sources for this study. Study Association This article is part of the thesis of course completion submitted by Luis Gustavo Albuquerque, from Universidade do Sul de Santa Catarina . Ethics approval and consent to participate This study was approved by the Ethics Committee of the Instituto de Cardiologia de Santa Catarina under the protocol number 1.519.838. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study.